PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
TI  - Everolimus Safe and Effective for Advanced pNET: Final Results of RADIANT-3
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 14--16
VI  - 14
IP  - 36
4099  - http://mdc.sagepub.com/content/14/36/14.2.short
4100  - http://mdc.sagepub.com/content/14/36/14.2.full
AB  - Final overall survival and safety results of the phase 3 Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor trial [RADIANT-3; NCT00412061] have bolstered previous findings that everolimus is effective and safe in the treatment of advanced pancreatic neuroendocrine tumors.